CHENODEOXYCHOLATE - THE BILE-ACID - THE DRUG - A REVIEW

被引:17
作者
BROUGHTON, G [1 ]
机构
[1] WILLIAM BEAUMONT ARMY MED CTR, DEPT SURG, EL PASO, TX USA
关键词
CHENODEOXYCHOLATE; BILE ACID; GALLSTONES; CEREBROTENDINOUS XANTHOMATOSIS; RHEUMATOID ARTHRITIS; CONSTIPATION; ERYTHROPOIETIC PROTOPORPHYRIA;
D O I
10.1097/00000441-199401000-00011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chenodeoxycholate (3 alpha, 7 alpha-dihydroxy-5 beta-cholanic acid) is a primary bile acid directly synthesized from cholesterol. It is an amphipathic molecule, possessing both a hydrophobic side and a polar hydrophilic side, giving it the ability to solubilize lipids in a water environment. Bile acids are necessary for the absorption of fats and fat soluble vitamins. Chenodeoxycholate inhibits the rate-limiting step of cholesterol synthesis, the formation of hydroxymethyl-glutaryl-coenzyme A. It was first reported to be useful in the dissolution of cholesterol gallstones in 1972. Today, chenodeoxycholate has other medicinal uses and is used for the management of cerebrotendinous xanthomatosis, hypertriglyceremia, congenital liver diseases, rheumatoid arthritis, and constipation. This article details some finer points of chenodeoxycholate biochemistry and physiology and discusses in some detail the current and past clinical uses of chenodeoxycholate. This is not an exhaustive discussion on gallstone dissolution therapies, but an overview of some of the lesser-known uses for this drug.
引用
收藏
页码:54 / 63
页数:10
相关论文
共 70 条
[11]  
BERINGER VM, 1984, NEW ENGL J MED, V311, P1649
[12]   BILE-ACID METABOLISM - ITS RELATION TO CLINICAL-DISEASE [J].
BERRY, W ;
REICHEN, J .
SEMINARS IN LIVER DISEASE, 1983, 3 (04) :330-340
[13]  
Bloch K, 1943, J BIOL CHEM, V149, P511
[14]  
BLOOMER JR, 1979, YALE J BIOL MED, V52, P39
[15]   ENZYMATIC REGULATION OF BILE ACID SYNTHESIS [J].
BOYD, GS ;
PERCYROB.IW .
AMERICAN JOURNAL OF MEDICINE, 1971, 51 (05) :580-&
[16]   THE PREVENTION OF CHOLELITHIASIS WITH INFUSED SODIUM CHENODEOXYCHOLATE IN THE PRAIRIE DOG (CYNOMYS-LUDOVICIANUS) [J].
BROUGHTON, G ;
TSENG, A ;
FITZGIBBONS, R ;
TYNDALL, S ;
STANISLAV, G ;
RONGONE, EL .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-PHYSIOLOGY, 1991, 99 (04) :609-613
[17]  
BRUUSGAARD A, 1976, LANCET, V1, P700
[18]   CHENODEOXYCHOLIC ACID AND URSODEOXYCHOLIC ACID EFFECTS IN ENDOGENOUS HYPERTRIGLYCERIDEMIAS - A CONTROLLED DOUBLE-BLIND TRIAL [J].
CARULLI, N ;
DELEON, MP ;
PODDA, M ;
ZUIN, M ;
STRATA, A ;
FRIGERIO, G ;
DIGRISOLO, A .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (10) :436-442
[19]   DISAPPEARANCE OF STONE SHADOWS IN POSTOPERATIVE CHOLANGIOGRAMS [J].
COLE, WH ;
HARRIDGE, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1957, 164 (03) :238-243
[20]  
COWEN AE, 1975, GASTROENTEROLOGY, V69, P59